The success of nanomedicine
- PMID: 34707725
- PMCID: PMC7611893
- DOI: 10.1016/j.nantod.2020.100853
The success of nanomedicine
Abstract
In recent years, the promise and prospects of nanomedicine have been controversially discussed. We here argue that nanomedicine has undeniably been successful, not only academically and preclinically, but also industrially and clinically. To ensure that we keep on making progress, we have to move away from over-focusing on nano and on materials, towards more holistic approaches that address real medical problems, in a realistic manner.
References
-
- Ledford H. Bankruptcy filing worries developers of nanoparticle cancer drugs. Nature. 2016;533:304–305. - PubMed
-
- Williams C. Here’s why Cerulean Pharma Inc (CERU) shares are falling 65% Smarter Analyst. 2017
-
- Wilhelm S, Tavares A, Dai Q, Ohta S, Audet J, Dvorak H, Chan W. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1:16014
-
- Service R. US Cancer institute cancels nanotech research centers. Science. 2019 doi: 10.1126/science.aay0798. - DOI
-
- Park K. The beginning of the end of the nanomedicine hype. J Control Release. 2019;305:221–222. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources